CCU Pediatric Oncology

The goal of the Clinical Cooperation Unit (CCU) Pediatric Oncology is to advance the therapy for children and adolescence with neuronal malignancies including brain tumors. Epigenetic regulation plays an important role in stem cell biology, differentiation and development. Our research aims to elucidate the molecular biology of epigenetic programs in order to develop individualized targeted treatment concepts with the goal to conduct phase I-III clinical trials in pediatric oncology based on molecular rationales.

Please find more information about our work on the DKFZ pages of the CCU Pediatric Oncology.